Clinical Trial Update: A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2） [Phase 3]

View source ↗

Summary

Phase 3 study CM310 for chronic rhinosinusitis with nasal polyposis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyposis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Rhinosinusitis With Nasal Polyposis | Phase 3 | Status: COMPLETED